About Daniel Lim

Daniel Lim is an IP litigation partner specialising in high-stakes life science patent litigation, particularly in the pharmaceutical industry, diagnostics and the emerging fields of precision medicine and cell and gene therapy. His previous case experience covers a broad range of technical fields, including oncology, molecular diagnostics and biostatistics, often involving issues at the cutting edge of the law, notably in relation to second medical-use patents. Daniel is widely sought for comment on life science and IP topics, and is particularly regarded as a thought leader on CRISPR gene editing. He is active as a member of AIPPI and EPLAW, including as vice-chair of AIPPIā€™s standing committee on biotechnology, and formerly served as Associate to Justice Yates of the Federal Court of Australia.